Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 24, 2023
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
[ Mon, Jul 24th 2023
] - WOPRAI
Edward White Reiterated (SNDX) at Strong Buy with Increased Target to $38 on, Jul 24th, 2023
Edward White of HC Wainwright & Co., Reiterated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $36 to $38 on, Jul 24th, 2023.
Edward has made no other calls on SNDX in the last 4 months.
There are 3 other peers that have a rating on SNDX. Out of the 3 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Edward
- Michael Schmidt of "Guggenheim" Initiated at Strong Buy and Held Target at $40 on, Tuesday, July 11th, 2023
- Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $31 on, Wednesday, May 10th, 2023
